Journal Orthopaedi and Traumatology Surabaya

Journal Orthopaedi and Traumatology Surabaya (JOINTS)

ISSN: 2460-8742 (Online) | ISSN: 2722-712X (Print)

The establishment of Journal Orthopaedi and Traumatology Surabaya, also known as JOINTS, was initiated by the desire of the Chairman of the Department of Orthopedics and Traumatology. The insufficient number of published research results led to the motivation of all doctors specializing in orthopedics and traumatology at Universitas Airlangga to create a platform for the publication of innovative research findings in the field of orthopedics and traumatology. The Department of Orthopedics and Traumatology launched JOINTS in 2012, and it was officially recognized as a journal on September 4, 2015, with the issuance of an ISSN for JOINTS by LIPI.

Journal Orthopaedi and Traumatology Surabaya (JOINTS) is an online peer-reviewed open-access journal established in 2012 by the Department of Orthopedic and Traumatology, Faculty of Medicine, Universitas Airlangga/Dr. Soetomo General Academic Hospital Surabaya in collaboration with the Indonesian Orthopaedic Association (PABOI) East Java branch. JOINTS is a biannual journal published two times a year in April and October. This journal encompasses original articles, case reports, and review articles in basic and clinical research in all fields of orthopaedic and traumatology. The journal only accepts manuscripts in English. JOINTS welcomes submissions from orthopedic researchers, practitioners, lecturers, and students from Indonesia and a broad range of other countries. 

JOINTS has been accredited by the National Journal Accreditation (ARJUNA) by the Ministry of Education, Culture, Research, and Technology of the Republic of Indonesia with the category of SINTA 3 (based on the Decree of the Director General of Higher Education, Research, and Technology Number 79/E/KPT/2023). Our journal has also been indexed in the ASEAN Citation Index (ACI), Directory of Open Access Journals (DOAJ), Crossref, Dimensions, Base, Google Scholar, and others.